PROCEPT BioRobotics Corporation
NASDAQ:PRCT
82 (USD) • At close January 14, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | PROCEPT BioRobotics Corporation |
Symbool | PRCT |
Munteenheid | USD |
Prijs | 82 |
Beurswaarde | 4,460,367,204 |
Dividendpercentage | 0% |
52-weken bereik | 44.02 - 103.81 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Dr. Reza Zadno Ph.D. |
Website | https://www.procept-biorobotics.com |
An error occurred while fetching data.
Over PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)